Fundraising Fox

Innervace

New York, US · Founded 2020 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

NH
Nader HalimNamed on SEC filing
AS
Althea StillmanNamed on SEC filing

Board

JL
Jonathan LeffBoard directorPartner at Deerfield Management Company
DG
David GreenwaldinBoard directorManaging Director at Deerfield Management Company

Investors · 2

BioAdvanceConshohocken · $500K – $1.5M
Deerfield Management CompanyreportedNew Yorkvia Jonathan Leff · board

Reported raises · per SEC filings

Form D private placements

$10M disclosed across 1 round · 2022

▶$10MraisedAug 2022 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nader HalimExecutive Officer, Director
  • Jonathan LeffDirector
  • Althea StillmanExecutive Officer, Director
  • David GreenwaldDirector
Offering amount
$40M
Amount sold
$10M
First sale
Aug 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Innervace's investors?
Innervace's investors include BioAdvance, Deerfield Management Company.
How much funding has Innervace raised?
Innervace has disclosed $10M raised across 1 round.
Where is Innervace headquartered?
Innervace is headquartered in New York, US.